The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
Open accessAbstract
miR-33 in Cholesterol Control: With the well-established link between serum cholesterol levels and cardiovascular disease and the availability of effective cholesterol-lowering drugs, cholesterol screening has rapidly become a routine part of health care. Yet, much remains to be learned about how cholesterol levels are regulated at the cellular level (see the Perspective by Brown et al. ). Now, Najafi-Shoushtari et al. (p. 1566 , published online 13 May) and Rayner et al. (p. 1570 , published online 13 May) have discovered a new molecular player in cholesterol control—a small noncoding RNA that, intriguingly, is embedded within the genes coding for sterol regulatory element-binding proteins (SREBPs), transcription factors already known to regulate cholesterol levels. This microRNA, called miR-33, represses expression of the adenosine triphosphate–binding cassette transporter A1, a protein that regulates synthesis of high-density lipoprotein (HDL, or “good” cholesterol) and that helps to remove “bad” cholesterol from the blood. Reducing the levels of miR-33 in mice boosted serum HDL levels, suggesting that manipulation of this regulatory circuit might be therapeutically useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pharmacological inhibition of miR-33 increased plasma high-density lipoprotein cholesterol levels in mice (Horie et al., 2010;Najafi-Shoushtari et al., 2010;Rayner et al., 2011a) and primates (Rayner et al., 2011b;Rottiers et al., 2013), leading to a marked reduction of atherosclerosis phenotypes.”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Najafi-Shoushtari et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in vivo antagonism or genetic deletion of miR-33 enhances hepatic ABCA1 expression and increases circulating HDL-cholesterol (HDL-C) (Marquart et al., 2010; Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These differences in miRNA expression vary between cell types suggesting that the role of miR-33b in the liver, where miR-33 is most highly expressed both in our mouse model and in human tissues (Najafi-Shoushtari et al., 2010), and other tissues may be considerably more important.”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In miR-33a knockout mice or when miR-33a is suppressed by synthetic nucleic acids such as antagomirs, the expression of ABCA1 in macrophages and the liver is increased 11 - 15) .”
From Critical Role of microRNA-33a/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MicroRNA (miR)-33 is known to target ABCA1 and ABCG1 in vivo.”
From MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice (2012) · cites this paper as [17]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two miR-33 genes are present in humans: miR-33b, which is present in intron 17 of the Srebp-1 gene on chromosome 17, and miR-33a, which is located in intron 16 of the Srebp-2 gene on chromosome 22.”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We and others have recently established that, during sterol-limited states, miR-33a is coincidentally generated with Srebp-2 transcription and works to increase cellular cholesterol levels by limiting cholesterol export through the down-regulation of ABC transporters, ABCA1 and ABCG1 (12–14).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“miR-33a and miR-33b are intronic miRNAs encoded within the SREBP-2 and SREBP-1 genes respectively (Marquart et al., 2010; Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“This work led to the demonstration that miR-33a and miR-33b are co-transcribed along with SREBP-2 and SREBP-1, and work in concert with their host genes to help maintain proper lipid levels within the cell (Davalos et al., 2011; Marquart et al., 2010; Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Genetic dissection of the impact of miR-33a and miR-33b during the progression of atherosclerosis (2017) · cites this paper as Najafi-Shoushtari et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“The most well-known target gene of miR-33a/b is ATP-binding cassette subfamily A member 1 (ABCA1).”
From Critical Role of microRNA-33a/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives (2026) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Recent reports, including ours, have indicated that miR-33 controls cholesterol homeostasis based on knockdown experiments using antisense technology.16–18”
From MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice (2012) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“We and others provided identification of a highly conserved miRNA family, miR-33, within the intronic sequences of the Srebp genes in organisms ranging from Drosophila to humans (11–14).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“In mice, however, there is only one miR-33 gene, which is conserved with human miR-33a and located within intron 15 of the mouse Srebp-2 gene.”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, these pathways regulate circulating HDL levels through their roles in HDL biogenesis and cellular cholesterol efflux (12–14).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [13]
In the citing paper
“These microRNAs participate in the regulation of cholesterol synthesis, fatty acid metabolism, and insulin signaling.”
From The Vasculature in Prediabetes (2018) · cites this paper as [143]
In the citing paper
“They are co-transcribed and act in conjunction with their host genes, Srebp1 and Srebp2, to regulate cholesterol synthesis.”
From The Vasculature in Prediabetes (2018) · cites this paper as [143]
In the citing paper
“Furthermore, an intronic microRNA located within Srebf2 gene, miR-33, inhibits the expression of Abca1 (Najafi-Shoushtari et al., 2010; Rayner et al., 2010).”
From Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP (2017) · cites this paper as Najafi-Shoushtari et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Identification of Mammalian microRNA Host Genes and Transcription Units
Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L., & Bradley, A. (2004) · Genome Research · doi:10.1101/gr.2722704 · Cited by 2,128
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1172/jci0215748 · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 957
Posttranscriptional Regulation of ATP-Binding Cassette Transporter A1 in Lipid Metabolism
Lv, Y.-C., Yin, K., Fu, Y., Zhang, D., Chen, W., & Tang, C. (2013) · DNA and Cell Biology · doi:10.1089/dna.2012.1940 · Cited by 36
Tian, G.-P., Tang, Y., He, P., Lv, Y.-C., Ouyang, X.-P., Zhao, G., Tang, S., Wu, J., Wang, J., Peng, J., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.109 · Cited by 36
Self-citationRole of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response
Zhong, H., Ma, M., Liang, T., & Guo, L. (2018) · Journal of Immunology Research · doi:10.1155/2018/2835761 · Cited by 36
Circulating miRNA-33: a potential biomarker in patients with coronary artery disease
Reddy, L. L., Shah, S. A. V., Ponde, C. K., Rajani, R. M., & Ashavaid, T. F. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1501760 · Cited by 37
Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology
Calderón‐Domínguez, M., Belmonte, T., Quezada-Feijoó, M., Ramos, M., Fernández‐Armenta, J., Pérez-Navarro, M. A., César, S., Peña-Peña, L., Vea, À., Llorente‐Cortés, V., et al. (2019) · Translational research · doi:10.1016/j.trsl.2019.08.007 · Cited by 36
Post-lanosterol biosynthesis of cholesterol and cancer
Lasunción, M. A., Martín-Sánchez, C., Canfrán‐Duque, A., & Busto, R. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.001 · Cited by 36
Liu, S., Sui, Q., Zhao, Y., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02045 · Cited by 36
Challenging Cellular Homeostasis: Spatial and Temporal Regulation of miRNAs
van Wijk, N., Zohar, K., & Linial, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416152 · Cited by 38
MicroRNAs in Macrophages: Regulators of Activation and Function
Sprenkle, N. T., Serezani, C. H., & Pua, H. H. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200467 · Cited by 39
Novel concepts in HDL pharmacology
Remaley, A. T., Norata, G. D., & Catapano, A. L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu141 · Cited by 36
Cui, H., Liu, Y., Liu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10309 · Cited by 35
Endoplasmic reticulum stress and focused drug discovery in cardiovascular disease
Yang, Y., Zhou, Q., Gao, A., Chen, L., & Li, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.031 · Cited by 35
Hromadníková, I., Kotlabová, K., & Krofta, L. (2022) · Biomedicines · doi:10.3390/biomedicines10030718 · Cited by 36
MicroRNA-33b downregulates the differentiation and development of porcine preadipocytes
Taniguchi, M., Nakajima, I., CHIKUNI, K., Kojima, M., Awata, T., & Mikawa, S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-013-2954-z · Cited by 35
Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC
Gabunia, K., Herman, A. B., Ray, M., Kelemen, S. E., England, R. N., Cadena, R. D., Foster, W. J., Elliott, K. J., Eguchi, S., & Autieri, M. V. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.02.005 · Cited by 35
Zambrano, T., Hirata, R. D. C., Hirata, M. H., et al. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.02.007 · Cited by 35
microRNA regulation of lipoprotein metabolism
Goedeke, L., Aranda, J. F., & Fernandez-Hernando, C. F. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000094 · Cited by 34
Sadegh, M. K., Ekman, M., Rippe, C., Uvelius, B., Swärd, K., & Albinsson, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035882 · Cited by 34
MicroRNA-33a/b in Lipid Metabolism
Ono, K., Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Yokode, M., Kita, T., & Kimura, T. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1252 · Cited by 34
MicroRNA-221 may be involved in lipid metabolism in mammary epithelial cells
Chu, M., Zhao, Y. M., Yu, S., Hao, Y., Zhang, P., Feng, Y., Zhang, H., Ma, D., Liu, J., Cheng, M. Y., et al. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.02.014 · Cited by 34
Promises of Nanotherapeutics in Obesity
Ash, G. I., Kim, D., & Choudhury, M. (2019) · Trends in endocrinology and metabolism · doi:10.1016/j.tem.2019.04.004 · Cited by 24
Genomic Variants and Multilevel Regulation of ABCA1, ABCG1, and SCARB1 Expression in Atherogenesis
Rozhkova, A. V., Dmitrieva, V. G., Nosova, E. V., Dergunov, A. D., Limborska, S. A., & Dergunova, L. V. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8120170 · Cited by 39
Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer’s Disease?
Codocedo, J. F., Ríos, J. A., Godoy, J. A., & Inestrosa, N. C. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9201-7 · Cited by 34
Liang, C., Wang, Z., Li, Y.-Y., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3679-5 · Cited by 34
Self-citationThe Complexity of Thyroid Transcription Factor 1 with Both Pro- and Anti-oncogenic Activities
Mu, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.491647 · Cited by 33
Post-transcriptional regulation in metabolic diseases
Kim, W., & Lee, E. K. (2012) · RNA Biology · doi:10.4161/rna.20091 · Cited by 33
miRNAs in non-alcoholic fatty liver disease
He, Z., Hu, C., & Jia, W. (2016) · Frontiers of Medicine · doi:10.1007/s11684-016-0468-5 · Cited by 33
Wang, J., Lu, R., Sun, J.-J., Xie, D., Yang, F., & Nie, G.-X. (2016) · Aquaculture Research · doi:10.1111/are.13228 · Cited by 33
miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming
Alamoudi, A. A., Alnoury, A., & Gad, H. (2017) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx023 · Cited by 35
SREBF1/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo
Nishino, T., Horie, T., Baba, O., Sowa, N., Hanada, R., Kuwabara, Y., Nakao, T., Nishiga, M., Nishi, H., Nakashima, Y., et al. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311409 · Cited by 33
Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells
Borji, M., Nourbakhsh, M., Shafiee, S. M., Owji, A. A., Abdolvahabi, Z., Hesari, Z., Ilbeigi, D., Seiri, P., & Yousefi, Z. (2019) · Biochemical Genetics · doi:10.1007/s10528-019-09905-5 · Cited by 33
MicroRNAs in Obesity-Associated Disorders: The Role of Exercise Training
Silveira, A. C., Gomes, J. L. P., Roque, F. R., Fernandes, T., & de Oliveira, E. M. (2022) · Obesity Facts · doi:10.1159/000517849 · Cited by 33
‘Micro‐managers’ of hepatic lipid metabolism and NAFLD
Liu, W., Cao, H., Yan, J., Huang, R., & Ying, H. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1295 · Cited by 33
Expression of miR-33 from an SREBF2 Intron Targets the FTO Gene in the Chicken
Shao, F., Wang, X., Yu, J., Jiang, H., Zhu, B., & Gu, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091236 · Cited by 33
MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
Sun, H., & Kemper, J. K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01072-3 · Cited by 35
D'Agostino, M., Martino, F., Sileno, S., Barillà, F., Beji, S., Marchetti, L., Gangi, F. M., Persico, L., Picozza, M., Montali, A., et al. (2017) · Clinical Science · doi:10.1042/cs20171121 · Cited by 32
Social status affects lipid metabolism in rainbow trout,Oncorhynchus mykiss
Kostyniuk, D. J., Culbert, B. M., Mennigen, J. A., & Gilmour, K. M. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00402.2017 · Cited by 32
Dissecting the roles of miR-140 and its host gene
Inui, M., Mokuda, S., Sato, T., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0077-4 · Cited by 32
Tian, J., Popal, M. S., Zhao, Y., Liu, Y., Chen, K., & Liu, Y. (2018) · Aging and Disease · doi:10.14336/ad.2018.1020 · Cited by 33
MicroRNA-33/33* inhibit the activation of MAVS through AMPK in antiviral innate immunity
Liu, D., Tan, Q., Zhu, J., Zhang, Y., Xue, Y., Song, Y., Liu, Y., Wang, Q., & Lai, L. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0326-x · Cited by 32
Qiu, R., Yu, X., Wang, L., Han, Z., Yao, C., Cui, Y., Hou, G., Dai, D., Jin, W., & Shen, N. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000060 · Cited by 36
Liao, W., Du, J., Wang, Z., Feng, Q., Liao, M., Liu, H., Yuan, K., & Zeng, Y. (2022) · International Journal of Cancer · doi:10.1002/ijc.34040 · Cited by 31
MicroRNAs as Regulators of Cancer Cell Energy Metabolism
Natarajaseenivasan, S. M., Velusamy, P., Mercy, C. S. A., Langford, D., Natarajaseenivasan, K., & Shanmughapriya, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081329 · Cited by 35
miRNAs in Lung Cancer: Large Roles for Small Players
Cherni, I., & Weiss, G. J. (2011) · Future Oncology · doi:10.2217/fon.11.74 · Cited by 33
Loh, W. P., Yang, Y., & Lam, K. (2017) · Biotechnology Journal · doi:10.1002/biot.201600488 · Cited by 33
Huang, J., Li, Y., Ma, F., et al. (2018) · Gene · doi:10.1016/j.gene.2018.09.012 · Cited by 32
Self-citationLDL Receptor Pathway Regulation by miR-224 and miR-520d
Salerno, A. G., van Solingen, C., Scotti, E., Wanschel, A. C. B. A., Afonso, M. S., Oldebeken, S. R., Spiro, W., Tontonoz, P., Rayner, K. J., & Moore, K. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00081 · Cited by 33
MicroRNAs in Liver Health and Disease
Hsu, S., & Ghoshal, K. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-012-0005-4 · Cited by 32
Evolutionary relationships between miRNA genes and their activity
Zhu, Y. Y., Skogerbø, G., Ning, Q., Wang, Z., Li, B., Yang, S., Sun, H., & Li, Y. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-718 · Cited by 31
Self-citationLee, S., Lee, M.-S., Chang, E., Lee, Y., Lee, J., Kim, J., Kim, C., Kim, I.-H., & Kim, Y. (2020) · Nutrients · doi:10.3390/nu12051499 · Cited by 31
MiRNAs in tuberculosis: Their decisive role in the fate of TB
Alipoor, S. D., Adcock, I. M., Tabarsi, P., Folkerts, G., & Mortaz, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173529 · Cited by 34
Epigenetics and cardiovascular risk in childhood
Martino, F., Magenta, A., Pannarale, G., Martino, E., Zanoni, C., Perla, F. M., Puddu, P. E., & Barillà, F. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000334 · Cited by 32
MicroRNA-126 participates in lipid metabolism in mammary epithelial cells
Chu, M., Zhao, Y. M., Feng, Y., Zhang, H., Liu, J., Cheng, M. Y., Li, L., Shen, W., Cao, H., Li, Q., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.039 · Cited by 32
Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer
Wei, Y., Zhu, M., & Schober, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061756 · Cited by 32
RNAs with multiple personalities
Maute, R. L., Dalla‐Favera, R., & Basso, K. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1193 · Cited by 30
Gene silencing approaches for the management of dyslipidaemia
Norata, G. D., Tibolla, G., & Catapano, A. L. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.010 · Cited by 30
Non-Coding RNAs and Lipid Metabolism
Smolle, E., & Haybaeck, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813494 · Cited by 32
Ballegaard, V., Ralfkiær, U., Pedersen, K. K., Hove‐Skovsgaard, M., Koplev, S., Brændstrup, P., Ryder, L. P., MADSEN, H. O., Gerstoft, J., Grønbæk, K., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001191 · Cited by 30
Alrob, O. A., Khatib, S. Y., & Naser, S. A. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0543-z · Cited by 31
Population variation in miRNAs and isomiRs and their impact on human immunity to infection
Rotival, M., Siddle, K. J., Silvert, M., Pothlichet, J., Quach, H., & Quintana‐Murci, L. (2020) · Genome biology · doi:10.1186/s13059-020-02098-w · Cited by 30
The Nuclear Receptor FXR Uncouples the Actions of miR-33 from SREBP-2
Tarling, E., Ahn, H., & Vallim, T. Q. D. A. (2015) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304179 · Cited by 33
Regulation of HDL Genes: Transcriptional, Posttranscriptional, and Posttranslational
Kardassis, D., Gafencu, A. V., Zannis, V. I., & Dávalos, A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_3 · Cited by 30
The diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 31
MicroRNAs and Lipoprotein Metabolism
Horie, T., Baba, O., Kuwabara, Y., Yokode, M., Kita, T., Kimura, T., & Ono, K. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.20859 · Cited by 29
The role of microRNAs in liver injury at the crossroad between hepatic cell death and regeneration
Lauschke, V. M., Mkrtchian, S., & Ingelman-Sundberg, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.084 · Cited by 29
Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers
Lu, Y., Jing, W., Feng, L., Zhang, L., Xu, J., You, T., & Zhao, J. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400052 · Cited by 29
Macrophage miRNAs in atherosclerosis
Karunakaran, D., & Rayner, K. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.006 · Cited by 29
Wang, H., Hu, Z.-B., Shi, F., Dong, J., Dang, L., Wang, Y., Sun, Z., Zhou, H., Zhang, S., Cao, X.-S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0210-5 · Cited by 28
Hinske, L. C., Heyn, J., Hübner, M., Rink, J., Hirschberger, S., & Kreth, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.175 · Cited by 28
Wang, Y., Hsi, E., Cheng, H., Hsu, S., Liao, Y., & Juo, S. H. (2017) · Oncotarget · doi:10.18632/oncotarget.18197 · Cited by 28
Advances and applications of environmental stress adaptation research
Hawkins, L. J., & Storey, K. B. (2019) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2019.110623 · Cited by 35
Pan, J. H., Cha, H., Tang, J., Lee, S., Lee, S. H., Le, B., Redding, M. C., Kim, S., Batish, M., Kong, B. C., et al. (2020) · Food & Function · doi:10.1039/d0fo02286a · Cited by 30
The roles of different microRNAs in the regulation of cholesterol in viral hepatitis
Meng, X., Eslami, Y., Derafsh, E., Saihood, A. S., Emtiazi, N., Yasamineh, S., Gholizadeh, O., & Pecho, R. D. C. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01250-w · Cited by 28
MicroRNAs as potential therapeutics for treating spinal cord injury.
Yan, H., Hong, P., Jiang, M. H., & Li, H. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.17.011 · Cited by 29
Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism
Arif, W., Datar, G. K., & Kalsotra, A. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.01.004 · Cited by 28
Veeraveedu, P. T., Ramamurthy, S., Wong, Z. W., Koo, B. J., Wong, J.-Y., Abdullah, M. F., Chin, Y. H., Chia, C. H., Tan, J. Y., Neo, W. T., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.10.020 · Cited by 28
An Intronic microRNA Links Rb/E2F and EGFR Signaling
Truscott, M., Islam, A. B. M. M. K., Lightfoot, J. W., López-Bigas, N., & Frolov, M. V. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004493 · Cited by 27
Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
Pulito, C., Sanli, T., Rana, P., Muti, P. C., Blandino, G., & Strano, S. (2013) · Metabolites · doi:10.3390/metabo3041051 · Cited by 27
Exploiting microRNAs for cell engineering and therapy
Bratkovič, T., Glavan, G., Štrukelj, B., Živin, M., & Rogelj, B. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.01.006 · Cited by 29
Chang, W., Zhang, L., Xian, Y., & Yu, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4236 · Cited by 27
Duan, L., Guo, L., Deng, B., Li, M., Yang, T., Yang, F., & Yang, Z. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9278 · Cited by 27
Ma, M., Yin, Z., Zhong, H., Liang, T., & Guo, L. (2018) · Genomics · doi:10.1016/j.ygeno.2018.08.004 · Cited by 26
Shao, F., Wang, X., Yu, J., Shen, K., Qi, C., & Gu, Z. (2019) · British Poultry Science · doi:10.1080/00071668.2018.1564242 · Cited by 24
Vyletelová, V., Nováková, M., & Pašková, Ľ. (2022) · Pharmaceuticals · doi:10.3390/ph15101278 · Cited by 30
Pek, S. L., Tavintharan, S., Woon, K., Lin, L., Ong, C. N., Lim, S. C., & Sum, C. F. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370215605588 · Cited by 26
Analysis of miRNAs and their target genes associated with lipid metabolism in duck liver
He, J., Wang, W., Lu, L., Tian, Y., Niu, D., Ren, J., Dong, L., Sun, S., Zhao, Y., Chen, L., et al. (2016) · Scientific Reports · doi:10.1038/srep27418 · Cited by 27
MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease
Liu, X. L., Cao, H. X., & Fan, J. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12408 · Cited by 26
Diao, L., Bai, L., Jiang, X., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28388 · Cited by 26
Smolka, C., Schlösser, D., Hohnloser, C., Bemtgen, X., Jänich, C., Schneider, L. A., Martin, J., Pfeifer, D., Moser, M., Hasselblatt, P., et al. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00364-6 · Cited by 27
Sommerauer, C., & Kutter, C. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00232.2022 · Cited by 27
Wang, W.-S., Du, Z.-Q., Cheng, B.-H., Wang, Y.-X., Yao, J., Li, Y.-M., Cao, Z.-P., Luan, P., Wang, N., & Li, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117843 · Cited by 30
Self-citationRoles of Thyroid Transcription Factor 1 in Lung Cancer Biology
Phelps, C. A., Lai, S., & Mu, D. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.05.007 · Cited by 28
microRNA-33 controls hunger signaling in hypothalamic AgRP neurons
Price, N. L., Fernández-Tussy, P., Varela, L., Cardelo, M. P., Shanabrough, M., Aryal, B., de Cabo, R., Suárez, Y., Horvath, T. L., & Fernández-Hernando, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46427-0 · Cited by 25
“…of miR-33a and miR-33b, are intronic miRNAs encoded within the sterol response binding protein 2 ( SREBP2 ) and SREBP1 genes, respectively 4,5 . miRNA-33a/b provide a critical link between the regulation of cholesterol and fatty acid biosynthesis by SREBPs, and cholesterol ef fl ux,…”
BackgroundInfluentialMicroRNAs in Cardiovascular Health: From Order to Disorder
Karunakaran, D., & Rayner, K. J. (2013) · Endocrinology · doi:10.1210/en.2013-1299 · Cited by 26
Hu, Y., Zhang, R., Zhang, Y., et al. (2012) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/2049-1891-3-16 · Cited by 25
Henderson, J., Pryzborski, S., Stratton, R. J., & O’Reilly, S. (2020) · Experimental Dermatology · doi:10.1111/exd.14136 · Cited by 25
Li, F., Hao, M., Feng, X., Zang, M., Qin, Y., Yi, S., Li, Z., Xu, Y., Zhou, L., Sui, W., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.04.010 · Cited by 25
Zhang, Q., You, C., Wang, S., Dong, Y., Monroig, Ó., Tocher, D. R., & Li, Y. (2016) · Scientific Reports · doi:10.1038/srep32909 · Cited by 25
Self-citationMicroRNAs in diagnosis and therapeutics
Atri, C., Guerfali, F. Z., & Laouini, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00006-3 · Cited by 25
Karolina, D. S., Armugam, A., Sepramaniam, S., & Jeyaseelan, K. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.21 · Cited by 25
Metadata
- Authors
- Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Näär, Anders M.
- ORCID
- Venue
- Science
- Published
- 2010-06-18
- Volume
- 328
- Issue
- 5985
- Pages
- 1566-1569
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3840500
- OpenAlex
- W2102901373
- Semantic Scholar
- 8e1f87e5a8c468d11cb938b52c20c8e6954402ce
- Cited by
- 957
- References
- 31
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 24 · 2023: 47 · 2022: 41 · 2021: 56 · 2020: 50 · 2019: 65 · 2018: 66 · 2017: 59 · 2016: 86 · 2015: 88 · 2014: 85 · 2013: 92 · 2012: 73
- FWCI
- 80.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM071449)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK084459, R01 DK48873, P30-DK34854, R01DK056626, R01 DK56626, R37DK048873, P30DK034854, R01DK048873)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- miR-33, cholesterol homeostasis, ABCA1, reverse cholesterol transport, HDL synthesis, cholesterol efflux, post-transcriptional regulation, antisense oligonucleotides, locked nucleic acid, cholesterol biosynthesis, cardiometabolic disease
- MeSH terms
- Animals, Cell Line, Cholesterol, Diet, Gene Expression Regulation, Homeostasis, Humans, Introns, Cholesterol, HDL, Liver, Macrophages, Mice, Inbred C57BL, Up-Regulation, Oligonucleotides, Antisense, ATP-Binding Cassette Transporters, 3' Untranslated Regions, RNA Interference, MicroRNAs, Mice, Sterol Regulatory Element Binding Proteins, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
